CancerSeq™ Plus Paraffin Tissue Tumor Sections: Breast

T2235086-SC-B906124 B906124
  • Species: Human
  • Applications: NGS, IHC, RNAScope
Need help with your order?
Find out more about placing an order here or contact us for technical support.
Pricing is for US customers only. For international pricing, please contact your local distributor. View Distributors Here.

Product Description

BioChain's CancerSeq™ Plus FFPE tissues have undergone a preliminary screening process to detect copy number variations (CNVs), single nucleotide polymorphisms (SNPs), and insertions/deletions (indels) in key cancer gene regions. These tissues serve as an optimal resource for validating methodologies and pinpointing new variants within tumors.

The DNA isolated from FFPE tissues is then analyzed for mutations using Next Generation Sequencing (NGS) technology, specifically employing ArcherDx's VariantPlex system. This targeted enrichment system focuses on 67 cancer-associated genes. It employs innovative techniques such as random start sites and unique fragment identification to create intricate libraries for thorough analysis.
Looking for multiple donors or additional samples?

Product Specifications

Features Specifications
Size 5 Curls
Shipping Ambient Temperature
Species Human
Sex Female
Age At Sampling 53 yrs
Tissue Breast
Diagnosis invasive (infiltrating) ductal carcinoma
Donor Status Tumor
Gene Characterization NGS
Product Type Tissue
Applications NGS, IHC, RNAScope
Clinical Diagnosis Invasive Ductal Carcinoma
Donor Information Female: 53 yrs old, 1 donor